Tag : IMMUNE CHECKPOINT INHIBITORS

Gastric cancer remains a major global health burden, ranking among the top five cancers worldwide in both incidence and mortality. Despite advances in surgery and systemic therapy, survival in locally advanced disease lags behind that of other common malignancies, such as colorectal or breast cancer.